A Look At Zentalis Pharmaceuticals (ZNTL) Valuation After Azenosertib Progress And Insider Buying [Yahoo! Finance]
Zentalis Pharmaceuticals Provides Corporate Update and Highlights Key Milestones and Expected Momentum in the Azenosertib Development Program for 2026
Incyclix Bio Expands Board of Directors with Appointment of Dr. Kimberly Blackwell [Yahoo! Finance]
Zentalis Pharmaceuticals: Hanging On For One Last Shot At PROC Approval [Seeking Alpha]
Zentalis Pharmaceuticals (NASDAQ:ZNTL) was upgraded by analysts at
Wall